Clinical Quality Assurance Manager WEP ClinicalClinical Quality Assurance ManagerCARemoteRole Objectives: The Clinical Quality Assurance Manager is responsible for the strategic leadership, oversight, and continuous improvement of the Good Clinical Practice (GCP) Quality Management System (QMS) supporting global clinical operations, including decentralised clinical trials (DCTs) involving nursing services and in-home patient care. The Clinical Quality Assurance Manager provides leadership to the Clinical QA team, partners with operational leadership across the organization, and serves as the primary quality advisor for clinical operations, regulatory inspections, Sponsor audits, and strategic business initiatives.
Network Strategic Partner Executive N-Power Medicine IncNetwork Strategic Partner ExecutiveCARemote$230,000–$270,000 / yearEstablish a consistent partner engagement cadence including quarterly business reviews, partner check-ins, onsite visits, and physician advisory boards, blending tactical, day-to-day conversations with strategic discussions on growth, expansion, and advocacy to keep the relationship active between formal touchpoints. This role partners closely with on-site implementation staff to ensure staff roll-out, EHR integration, and day-to-day program execution run smoothly, while also building the physician relationships, advisory boards, and education materials that keep the partnership growing.
Faculty Member - Affiliate Program Rotating Physician St. Jude Children's Research Hospital IncFaculty Member - Affiliate Program Rotating PhysicianCARemoteAll resumes submitted by search firms to any employee or other representative at St. Jude via email, the internet, or in any form and/or method without a valid written search agreement in place and approved by HR will result in no fee being paid in the event the candidate is hired by St. Jude is the only NCI-designated comprehensive cancer center devoted solely to children, offering specialized anesthesia services in oncology, pain management, and other catastrophic diseases affecting children.
Clinical Advisor - Oncology & Rare Disease Products (BCOP) CVS Health CorpClinical Advisor - Oncology & Rare Disease Products (BCOP)CARemote$135,575–$228,800 / yearDevelop cost management and population health programs such as formulary and coverage strategies, prior authorization programs, care management programs, patient and provider engagement programs, value-based arrangements, and more to promote the delivery of high-quality, safe, and effective programs which optimize health outcomes, improves the provider and member experience, and reduces costs for clients and members. This position will be responsible for driving growth in Specialty by 1) building innovative products that secure our position as the market leader in payor focused Specialty solutions and 2) creating disruptive and holistic solutions to address oncology, rare disease, and other high-cost therapies to ensure best in class management of cost and quality of care.
NewClinical Literature Curator NeoGenomics IncClinical Literature CuratorCARemoteReview, interpret, evaluate, synthesize, and summarize scientific literature and other publicly available sources, including PubMed, ClinicalTrials.gov, FDA publications, and related scientific resources, into accurate, clear, and concise clinical insights in accordance with SOPs. Position Summary: As a Clinical Literature Curator you will support NeoGenomics' scientific and medical intelligence programs by identifying, evaluating, and synthesizing scientific literature, clinical trial data, and other publicly available information related to oncology biomarkers and therapies.
Clinical Content- Physician (Clinical AI Strategist - UpToDate®, M.D.) Wolters Kluwer N.V.Clinical Content- Physician (Clinical AI Strategist - UpToDate®, M.D.)Torrance, CARemote$173,500–$310,000 / yearDemonstrated expertise in clinical reasoning as a discipline, including diagnostic reasoning, therapeutic decision making, uncertainty management, and evidence-based clinical decision making, as evidenced by teaching, publication, research, curriculum development, or related scholarly work. Contribute to clinical validation platform development, including development of clinical test sets, reasoning benchmarks, red teaming protocols, safety evaluations, and ongoing expert review to ensure outputs remain clinically faithful, useful, and meaningful.
Senior Director, AI Platform Architecture Thermo Fisher Scientific IncSenior Director, AI Platform ArchitectureCARemote$167,500–$278,000 / yearOperating in close partnership with Product, Data, and Engineering, the team embeds AI across our digital portfolio to accelerate clinical trial execution, enhance data-driven decision-making, and unlock differentiated value for our customers. At least 120 hours paid time off (PTO), 10 paid holidays annually, paid parental leave (3 weeks for bonding and 8 weeks for caregiver leave), accident and life insurance, and short- and long-term disability in accordance with company policy.
Senior Director, AI Risk and Compliance Thermo Fisher Scientific IncSenior Director, AI Risk and ComplianceCARemote$167,500–$278,000 / yearOperating in close partnership with Product, Data, and Engineering, the team embeds AI across our digital portfolio to accelerate clinical trial execution, enhance data-driven decision-making, and unlock differentiated value for our customers. This role operates as a peer to AI Engineering, Delivery, and AI Value Realization & Enablement (AVRE), providing independent oversight while partnering closely to embed governance-by-design into AI systems and delivery processes.
Director, Business Development ClinChoice IncDirector, Business DevelopmentCARemoteKeywords: Director of Business Development, business development, marketing, contracting, travel, clinical trials, CRO, Clinical Research Organization, clinical development, CRO management, relationship management, clinical research sales, account management, CRO full-service sales, Bid Defense, contract negotiations, business to business sales #LI-VH1 #LI-Remote #LI-Director #LI-FULLTIME. Strong negotiation skills with a proven track record of closing complex, multi-million-dollar business deals Persuasive and compelling presentation and communication skills, both written and verbal Ability to understand internal business need, interpret business challenges and present quick and responsive high-level solutions.
Senior Director, Advanced Technologies & Innovations iRhythm Holdings IncSenior Director, Advanced Technologies & InnovationsCARemote$222,000–$288,000 / yearReporting directly to the Chief Medical & Scientific Officer and EVP, Advanced Technologies, this leader will drive the needs finding, landscape exploration and idea sourcing, conception, feasibility, and translation of new capabilities across AI, sensors, digital biomarkers, and data science into differentiated clinical and commercial solutions that are readied for product development. The leader operates as an extension of executive leadership team, as the steward of the Innovation Committee, and acts as a key integrator across the business, driving complex cross-functional initiatives across Product, Business Development, R&D, Science, Regulatory, Clinical, Commercial, and Corporate Strategy organizations.
Senior Director, Pharmacovigilance (Post-Marketing) IRESenior Director, Pharmacovigilance (Post-Marketing)Sherman Oaks, CaliforniaRemoteStrong grasp of financial drivers (profitability, cost control, margins) and proven ability to collaborate with internal stakeholders to deliver projects aligned with sound financial and operational practices, ensuring optimal efficiency. Drive efficiency and productivity to maximize revenue and optimize costs, while supporting new business development and ensuring the profitability of ongoing work through effective management of change orders.
Associate Director, Market Development, Oncology & Emerging Markets Oxford Nanopore Technologies PlcAssociate Director, Market Development, Oncology & Emerging MarketsCARemote$160,000–$185,000 / yearOxford Nanopore Technologies is seeking an experienced market development leader to expand adoption of our sequencing technology across oncology and other high-growth markets in the Americas. You will work across sales, marketing, product, medical, regulatory, and government affairs teams to help move promising applications from early research use toward broader adoption and scale.
Director, Early Development - Clinical Science Tarsus PharmaceuticalsDirector, Early Development - Clinical ScienceIrvine, CaliforniaRemote$203,200–$284,600 / yearLeadership Competencies - This role requires mastery of the Tarsus Leadership Competencies for Leading People, including: Decision Making - Demonstrates strong decision-making by applying structured analysis to complex challenges, balancing competing priorities and long-term impacts while engaging stakeholders and driving solutions aligned with organizational goals. Outcome Driven - Demonstrates strong outcomes focus by aligning teams around shared priorities, proactively addressing risks and dependencies, and driving cross-functional accountability to sustain progress and deliver results.
Director, Early Development - Clinical Science Tarsus Pharmaceuticals IncDirector, Early Development - Clinical ScienceIrvine, CARemote$203,200–$284,600 / yearLeadership Competencies - This role requires mastery of the Tarsus Leadership Competencies for Leading People, including: Decision Making - Demonstrates strong decision-making by applying structured analysis to complex challenges, balancing competing priorities and long-term impacts while engaging stakeholders and driving solutions aligned with organizational goals. Let's talk about some of the key responsibilities of the role: Maintains direct ownership of early development clinical deliverables, actively contributing to protocol development, document authoring, data review, study-level problem solving and execution decisions to ensure scientific rigor and operational excellence.
Medical Science Liaison Immunology - Admilparant (Los Angeles, CA, HI) Bristol Myers SquibbMedical Science Liaison Immunology - Admilparant (Los Angeles, CA, HI)Los Angeles, CARemote$166,090–$201,262 / yearThe purpose of their interactions is to engage in meaningful scientific exchange that will ensure patients have access to BMS medicines, to ensure their safe and appropriate use through peer to peer discussions aligned with medical strategies and needs expressed by external stakeholders, and to facilitate research. Based on eligibility*, additional time off for employees may include unlimited paid sick time, up to 2 paid volunteer days per year, summer hours flexibility, leaves of absence for medical, personal, parental, caregiver, bereavement, and military needs and an annual Global Shutdown between Christmas and New Years Day.
Medical Science Liaison, Cardiovascular - Milvexian (Los Angeles, HI) Bristol Myers SquibbMedical Science Liaison, Cardiovascular - Milvexian (Los Angeles, HI)Los Angeles, CARemote$166,090–$201,262 / yearThe purpose of their interactions is to engage in meaningful scientific exchange that will ensure patients have access to BMS medicines, to ensure their safe and appropriate usethrough peer to peer discussions aligned with medical strategies and needs expressed by external stakeholders, and to facilitate research. Based on eligibility*, additional time off for employees may include unlimited paid sick time, up to 2 paid volunteer days per year, summer hours flexibility, leaves of absence for medical, personal, parental, caregiver, bereavement, and military needs and an annual Global Shutdown between Christmas and New Years Day.
Senior Director, Pharmacovigilance (Post-Marketing) ICON PlcSenior Director, Pharmacovigilance (Post-Marketing)Sherman Oaks, CARemote$178,008–$222,510 / yearStrong grasp of financial drivers (profitability, cost control, margins) and proven ability to collaborate with internal stakeholders to deliver projects aligned with sound financial and operational practices, ensuring optimal efficiency. Drive efficiency and productivity to maximize revenue and optimize costs, while supporting new business development and ensuring the profitability of ongoing work through effective management of change orders.
Medical Science Liaison (MSL)/Senior Medical Science Liaison (MSL) - West Coast Kyverna Therapeutics IncMedical Science Liaison (MSL)/Senior Medical Science Liaison (MSL) - West CoastCARemote$170,000–$185,000 / yearThe MSL will serve as a field-based scientific expert supporting external engagement with healthcare professionals, investigators, treatment centers, and key opinion leaders (KOLs) focused on autoimmune diseases and cell therapy. Identify, establish, and maintain high‑quality scientific relationships with key opinion leaders (KOLs), investigators, academic medical centers, community physicians, pharmacists, nurses, and treatment centers within the assigned territory.
Clinical Scientist Balt GroupClinical ScientistIrvine, CaliforniaRemote$160,000–$170,000 / yearThe Clinical Evidence organization supports R&D, designs and analyzes clinical trials (from FIM to Pivotal trials; post-market-research, US or International) and supports the needs of clinical operations (protocol development, clinical study report development). Authors Clinical Evidence reporting deliverables, including Clinical Study Reports, regulatory responses, and other related documentationDemonstrate strong medical writing skills, with a minimum experience of 2 years of writing CIPs, CSRs in medical device industry.
Director, Medical Science Liaison Southern California Revolution Medicines IncDirector, Medical Science Liaison Southern CaliforniaCARemote$236,000–$259,000 / yearKey aspects of this role will include engage in peer-to-peer scientific dialogue with healthcare professionals that translate into meaningful insights, serve as a therapeutic expert and thought partner to internal teams, liaison between Revolution Medicines and clinical study sites / investigators, and provide support for medical education, advisory boards, and medical congresses. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development.